Interestingly, there was a significant increase in Lpcat2 (4‐fold) and cPla2 (3‐fold) for the mice that developed NASH (32‐week WD), whereas no change in Alox15 was observed across groups (Fig. 7C). This evidence concerns the gene LPCAT2 and Wilson disease.